Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxorubicin-loaded SAP microspheres in resectable HCC
NCT01116635Phase 2Completed
- Sponsor
- University of British Columbia
- Start
- Jan 2010
- Primary completion
- Jan 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in hepatocellular carcinoma (HCC), sponsored by University of British Columbia. Started Jan 2010; status: completed.
02
Drugs
doxorubicin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01116635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116635.